1. 2022
  2. Can Hysterosalpingo-Foam Sonography Replace Hysterosalpingography as First-Choice Tubal Patency Test? A Randomized Non-inferiority Trial

    van Welie, N., van Rijswijk, J., Dreyer, K., van Hooff, M. H. A., de Bruin, J. P., Verhoeve, H. R., Mol, F., van Baal, W. M., Traas, M. A. F., van Peperstraten, A. M., Manger, A. P., Gianotten, J., de Koning, C. H., Koning, A. M. H., Bayram, N., van der Ham, D. P., Vrouenraets, F. P. J. M., Kalafusova, M., van de Laar, B. I. G., Kaijser, J., & 14 othersLambeek, A. F., Meijer, W. J., Broekmans, F. J. M., Valkenburg, O., van der Voet, L. F., van Disseldorp, J., Lambers, M. J., Tros, R., Lambalk, C. B., Stoker, J., van Wely, M., Bossuyt, P. M. M., Mol, B. W. J. & Mijatovic, V., 1 Aug 2022, In: Obstetrical and Gynecological Survey. 77, 8, p. 481-483 3 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  3. Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?

    Lof, P., van de Vrie, R., Korse, C. M., van Gent, M. D. J. M., Mom, C. H., Rosier - van Dunné, F. M. F., van Baal, W. M., Verhoeve, H. R., Hermsen, B. B. J., Verbruggen, M. B., Hemelaar, M., van de Swaluw, A. M. G., Knipscheer, H. C., Huirne, J. A. F., Westenberg, S. M., van der Noort, V., Amant, F., van den Broek, D. & Lok, C. A. R., Aug 2022, In: Gynecologic oncology. 166, 2, p. 284-291 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Can hysterosalpingo-foam sonography replace hysterosalpingography as first-choice tubal patency test? A randomized non-inferiority trial: A randomized non-inferiority trial

    van Welie, N., van Rijswijk, J., Dreyer, K., van Hooff, M. H. A., Bruin, J. P. D., Verhoeve, H. R., Mol, F., van Baal, W. M., Traas, M. A. F., van Peperstraten, A. M., Manger, A. P., Gianotten, J., de Koning, C. H., Koning, A. M. H., Bayram, N., van der Ham, D. P., Vrouenraets, F. P. J. M., Kalafusova, M., van de Laar, B. I. G., Kaijser, J., & 14 othersLambeek, A. F., Meijer, W. J., Broekmans, F. J. M., Valkenburg, O., van der Voet, L. F., van Disseldorp, J., Lambers, M. J., Tros, R., Lambalk, C. B., Stoker, J., van Wely, M., Bossuyt, P. M. M., Mol, B. W. J. & Mijatovic, V., 1 May 2022, In: Human reproduction (Oxford, England). 37, 5, p. 969-979 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    van Dijk, M. M., Vissenberg, R., Fliers, E., van der Post, J. A. M., van der Hoorn, M-L. P., de Weerd, S., Kuchenbecker, W. K., Hoek, A., Sikkema, J. M., Verhoeve, H. R., Broeze, K. A., de Koning, C. H., Verpoest, W., Christiansen, O. B., Koks, C., de Bruin, J. P., Papatsonis, D. N. M., Torrance, H., van Wely, M., Bisschop, P. H., & 1 othersGoddijn, M., 1 May 2022, In: Lancet. Diabetes and endocrinology. 10, 5, p. 322-329 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the ‘Dutch Gynecological Oncology Audit’

    the participants of the Dutch Gynecological Oncology Collaborator group, May 2022, In: Gynecologic oncology. 165, 2, p. 330-338 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Endometriosis centers of expertise in the Netherlands: Development toward regional networks of multidisciplinary care

    de Kok, L., van Hanegem, N., van Kesteren, P., Klinkert, E., Maas, J., Mijatovic, V., Rhemrev, J., Verhoeve, H. & Nap, A., 1 Jan 2022, In: Health Science Reports. 5, 1, e447.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  8. 2021
  9. Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the Dutch Gynecological Oncology Audit (DGOA)

    On behalf of the participants of the Dutch Gynecological Oncology Collaborator Group, Aug 2021, In: Gynecologic oncology. 162, 2, p. 331-338 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Clinical auditing as an instrument to improve care for patients with ovarian cancer: The Dutch Gynecological Oncology Audit (DGOA)

    participants of the Dutch Gynecological Oncology Collaborator Group, Jul 2021, In: European journal of surgical oncology. 47, 7, p. 1691-1697 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Transfer of fresh or frozen embryos: a randomised controlled trial

    Wong, K. M., van Wely, M., Verhoeve, H. R., Kaaijk, E. M., Mol, F., van der Veen, F., Repping, S. & Mastenbroek, S., 1 Apr 2021, In: Human reproduction (Oxford, England). 36, 4, p. 998-1006 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  12. Comparing the cumulative live birth rate of cleavage-stage versus blastocyst-stage embryo transfers between IVF cycles: A study protocol for a multicentre randomised controlled superiority trial (the ToF trial)

    Cornelisse, S., Ramos, L., Arends, B., Brink-van der Vlugt, J. J., de Bruin, J. P., Curfs, M. H. J. N., Derhaag, J., van Dongen, A., van Echten-Arends, J., Groenewoud, E. R., Maas, J. W. M., Pieterse, Q., van Santbrink, E. J. P., Slappendel, E., Traas, M. A. F., Visser, J., Vergouw, C. G., Verhoeve, H. R., van der Westerlaken, L. A. J., Wurth, Y., & 5 othersvan der Zanden, M., Braat, D. D. M., van Wely, M., Mastenbroek, S. & Fleischer, K., 13 Jan 2021, In: BMJ open. 11, 1, e042395.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 Next

ID: 5179279